Education
About Us
Working with TipRanks
Follow Us
Mannkind Corp. (MNKD)
NASDAQ:MNKD
Earnings Data
Report Date
Mar 03, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
<0.01Last Year’s EPS
0.03Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue performance driven by Tyvaso DPI and Afrezza, alongside strategic growth initiatives such as the acquisition of scPharmaceuticals. However, challenges such as a decline in VGo revenue and increased SG&A expenses were noted. Overall, the positive aspects of revenue growth and strategic acquisitions outweighed the lowlights.Company Guidance
Record Revenue in Q3 2025
MannKind Corporation delivered a record revenue quarter of $82 million, primarily driven by strong performance from Tyvaso DPI and Afrezza.
Acquisition of scPharmaceuticals
MannKind completed the acquisition of scPharmaceuticals, enhancing its portfolio and expanding its footprint into cardiorenal medicine.
Strong Performance of Tyvaso DPI
Tyvaso DPI generated $33 million in royalties and $26 million in manufacturing-related revenue, marking the highest revenue quarter for the product.
FUROSCIX Revenue Growth
FUROSCIX revenue reached $47.1 million year-to-date, a 95% increase over the same period in 2024, with over 27,000 doses dispensed in Q3 2025, up 153% from the previous year.
Afrezza Prescription Growth
Afrezza saw a 31% increase in new prescriptions and a 27% increase in total prescriptions year-over-year, with net revenue up 23% in Q3 2025 compared to Q3 2024.
MNKD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MNKD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $5.48 | $6.06 | +10.58% |
Aug 06, 2025 | $3.99 | $3.46 | -13.28% |
May 08, 2025 | $4.85 | $4.63 | -4.54% |
Feb 26, 2025 | $5.47 | $5.23 | -4.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Mannkind Corp. (MNKD) report earnings?
Mannkind Corp. (MNKD) is schdueled to report earning on Mar 03, 2026, TBA (Confirmed).
What is Mannkind Corp. (MNKD) earnings time?
Mannkind Corp. (MNKD) earnings time is at Mar 03, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MNKD EPS forecast?
MNKD EPS forecast for the fiscal quarter 2025 (Q4) is <0.01.